All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @jeffunbreakableblack on TikTok · 65s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @jeffunbreakableblack's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'll tell you all about peptide I like called 5 Amino 1NQ.
  2. 0:03It works really good on your NAD pathways.
  3. 0:05That's the longevity stuff everyone sees from the IVs
  4. 0:08and all that.
  5. 0:09It actually helps by inhibiting something else in an MT,
  6. 0:12I believe in your body which helps bring up your NAD level.
  7. 0:15So there are a few things I really love about this one,
  8. 0:18a drop body fat like crazy.
  9. 0:20As you can see in this photo here, I was thick and juicy,
  10. 0:22but I was thick and juicy a little bit leaner.
  11. 0:24I had a lot of explosive energy.
  12. 0:26It was like a lot back being in my late 20s and early 30s.
  13. 0:29I was able to push through just the way I could handle things.
  14. 0:32Just felt a lot different like back.
  15. 0:34Just looking at just the eccentric.
  16. 0:36So it was just great abundance of energy.
  17. 0:38I actually got annoying because I was only sleeping
  18. 0:40like five, six, six and a half hours.
  19. 0:43I wake up full of energy.
  20. 0:45And then the other thing that I have to say about it
  21. 0:47that I really, really enjoyed was just the way I felt.
  22. 0:50It was overall good, a little boost and everything like that.
  23. 0:52It's very, very pricey.
  24. 0:54I did it for six weeks.
  25. 0:55I do think after four weeks it kind of eh.
  26. 0:57So I would recommend a four weeks on,
  27. 0:58maybe four weeks off or eight weeks off and do it.
  28. 1:00But it's definitely a heavy hitter.
  29. 1:02If you want to spend the money on it,
  30. 1:03can't recommend it enough.

Peptide therapy TikTok claims: what the science actually supports

Jeff Black

TikTok creator

16.9K viewsWatch on TikTok

Quick answer

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that has demonstrated fat reduction and metabolic improvements in diet-induced obese mouse models, with the proposed mechanism involving increased NAD+ bioavailability through preserved nicotinamide substrate. As of 2024, no peer-reviewed human clinical trials have been published on this compound, meaning all human reports including those in this video are anecdotal. Individuals using 5-Amino-1MQ outside of a supervised clinical setting should be aware that dosing, safety, and efficacy data in humans remain entirely unestablished.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Peptide therapy TikTok claims: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Peptide therapy TikTok claims: what the science actually supports is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Peptide therapy TikTok claims: what the science actually supports" from Jeff Black. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that has demonstrated fat reduction and metabolic improvements in diet-induced obese mouse models, with the proposed mechanism involving increased NAD+ bioavailability through preserved nicotinamide substrate.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7473574149210885422." In this clip, the useful excerpt is: "I'll tell you all about peptide I like called 5 Amino 1NQ." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The most rigorous published data comes from a 2021 Nature Communications study (Neelakantan et al.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that has demonstrated fat reduction and metabolic improvements in diet-induced obese mouse models, with the proposed mechanism involving increased NAD+ bioavailability through preserved nicotinamide substrate.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • 5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) that has demonstrated fat reduction and metabolic improvements in diet-induced obese mouse models, with the proposed mechanism involving increased NAD+ bioavailability through preserved nicotinamide substrate. As of 2024, no peer-reviewed human clinical trials have been published on this compound, meaning all human reports including those in this video are anecdotal. Individuals using 5-Amino-1MQ outside of a supervised clinical setting should be aware that dosing, safety, and efficacy data in humans remain entirely unestablished.
  • 5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. The distinction matters for how the compound is classified, sourced, and regulated.
  • The most rigorous published data comes from a 2021 Nature Communications study (Neelakantan et al.) showing fat reduction in diet-induced obese mice, not in humans.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • 5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. The distinction matters for how the compound is classified, sourced, and regulated.
  • The most rigorous published data comes from a 2021 Nature Communications study (Neelakantan et al.) showing fat reduction in diet-induced obese mice, not in humans.
  • NNMT inhibition raises NAD+ by preserving nicotinamide substrate, a real and studied mechanism, but human pharmacokinetics for this compound remain unpublished.
  • Zero peer-reviewed human clinical trials on 5-Amino-1MQ existed as of mid-2024, making all human benefit claims, including energy, fat loss, and sleep changes, anecdotal only.
  • Cycling recommendations like four weeks on and four-to-eight weeks off have no pharmacological evidence base and should not be treated as clinical guidance.
  • The compound is typically sold through research chemical suppliers or compounding pharmacies, where purity and quality controls vary significantly and are not federally standardized.
  • Anyone curious about NNMT inhibition or NAD+ metabolism should consult a licensed clinician before use, not base decisions on personal testimony from a 60-second video.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @jeffunbreakableblack actually say?

Jeff talked up a compound called 5-Amino-1MQ, which he described as working "really good on your NAD pathways" by inhibiting something in the mitochondria to raise NAD levels. His personal claims were specific: he said it made him drop body fat "like crazy," gave him "a lot of explosive energy," and cut his sleep needs down to five or six hours while leaving him fully rested. He ran it for six weeks and recommended a four-week-on, four-to-eight-week-off cycle. He also flagged the cost as significant. One correction worth noting upfront: he called it a peptide, which is technically wrong. 5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. That's not a minor detail.

Does the science back this up?

The NAD+ mechanism Jeff described is real, but his explanation has a gap. 5-Amino-1MQ works by inhibiting nicotinamide N-methyltransferase, or NNMT, an enzyme that consumes SAM and processes nicotinamide. By blocking NNMT, you preserve more nicotinamide for NAD+ synthesis. That part is legitimate biochemistry. The fat loss angle also has some animal support. Improving NAD+ availability affects SIRT1 activity and metabolic rate in adipose tissue. A 2021 study by Neelakantan et al. in Nature Communications showed 5-Amino-1MQ reduced adiposity in diet-induced obese mice. The energy and sleep claims, however, are where the evidence essentially runs out. Those are anecdotal, and the compound has not been studied in humans in any published clinical trial as of mid-2024.

What did they get wrong (or right)?

He got the broad mechanism directionally right, which is more than most influencers manage. NNMT inhibition does connect to NAD+ metabolism, and the Neelakantan mouse data on fat loss is real. Credit where it's due.

But here's what he got wrong:

  • He called it a peptide. It isn't. 5-Amino-1MQ is a small-molecule NNMT inhibitor. This matters because regulatory and safety frameworks differ significantly between peptides and small molecules.
  • His claim about sleeping "five, six hours" and waking "full of energy" is purely anecdotal. There is no published human data on 5-Amino-1MQ and sleep architecture.
  • Describing explosive energy reminiscent of his late 20s is not a documented effect. It's a felt experience that could involve placebo response, lifestyle factors, or other compounds used simultaneously.
  • His cycle recommendation of four weeks on, four-to-eight weeks off has no clinical basis. That timing appears to be entirely self-derived.

The bigger issue is that this compound has zero published human trials. Extrapolating from mouse adiposity studies to personal fat loss and energy transformation is a significant leap.

What should you actually know?

5-Amino-1MQ is a research compound with genuine mechanistic interest but no human clinical trial data. The mouse studies are intriguing. The jump from "reduced adiposity in obese mice" to "drop body fat like crazy" in humans is not supported by evidence. NAD+ biology is genuinely complex, and NNMT inhibition is one of several ways to influence it, but we don't yet know how this translates to human metabolism, what the optimal dosing looks like, or what the long-term safety profile is. The cost Jeff mentioned is real. This compound is typically expensive and sold through research chemical suppliers or compounding pharmacies, which means quality and purity are not guaranteed. Anyone considering it should work with a licensed clinician, not a TikTok cycle recommendation, before touching it.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jeff Black · TikTok creator

16.9K views on this video

Peptide therapy TikTok claims: what the science actually supports

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about 5-amino-1mq?

5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. The distinction matters for how the compound is classified, sourced, and regulated.

What does the video say about the most rigorous published data comes from a 2021 nature?

The most rigorous published data comes from a 2021 Nature Communications study (Neelakantan et al.) showing fat reduction in diet-induced obese mice, not in humans.

What does the video say about nnmt inhibition raises nad+ by preserving nicotinamide substrate, a real?

NNMT inhibition raises NAD+ by preserving nicotinamide substrate, a real and studied mechanism, but human pharmacokinetics for this compound remain unpublished.

What does the video say about zero peer-reviewed human clinical trials on 5-amino-1mq existed as of?

Zero peer-reviewed human clinical trials on 5-Amino-1MQ existed as of mid-2024, making all human benefit claims, including energy, fat loss, and sleep changes, anecdotal only.

What does the video say about cycling recommendations like four weeks on?

Cycling recommendations like four weeks on and four-to-eight weeks off have no pharmacological evidence base and should not be treated as clinical guidance.

What does the video say about the compound?

The compound is typically sold through research chemical suppliers or compounding pharmacies, where purity and quality controls vary significantly and are not federally standardized.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jeff Black, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.